$ACHV SEC Filings

Filed On	Filing
06 Oct 2026	Form 4: Halladay Benjamin, Chief Financial Officer Granted 200,000 Stock Option (right to buy) · Granted 200,000 Restricted Stock Unit (RSU)
06 Oct 2026	Form 3: Halladay Benjamin, Chief Financial Officer No securities owned
01 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On October 1, 2026, Achieve Life Sciences, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) appointed Benjamin Halladay as the Company’s Chief Financial Officer and “principal financial officer,” ef...
21 Aug 2026	Form 4: Stewart Richard Alistair, Director Sold 20,626 shares ($175K)
19 Aug 2026	144
17 Aug 2026	SCHEDULE 13G
14 Aug 2026	424B5
14 Aug 2026	8-K: Other Events
13 Aug 2026	SCHEDULE 13G
11 Aug 2026	10-Q
11 Aug 2026	8-K: Results of Operations and Financial Condition
29 Jul 2026	Form 4: Sellig Thomas, Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
29 Jul 2026	Form 4: Martin Christopher Nathan, Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
29 Jul 2026	Form 4: Royston Aaron, Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
29 Jul 2026	Form 4: Waldman Reid Alexander, Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
29 Jul 2026	Form 4: Stewart Richard Alistair, Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
29 Jul 2026	Form 4: Farrow Jeffrey S, Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
29 Jul 2026	Form 4: Phelan Nancy R., Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
28 Jul 2026	SCHEDULE 13G/A
27 Jul 2026	SCHEDULE 13G

Comments